Review article · 2017 · Open access

The prebiotic landscape: history, health and physiological benefits, and regulatory challenges – an IPA perspective part 1

S.H. Saville, J.A. Younes, George Paraskevakos, Koen Venema

Beneficial Microbes, 16(1), 1–33 · Published 1 January 2017 · DOI 10.1163/18762891-bja00056

Read the free full textCite this paper

In brief

“The prebiotic landscape: history, health and physiological benefits, and regulatory challenges – an IPA perspective part 1” is a 2017 review article by S.H. Saville and 3 co-authors, published in Beneficial Microbes. OpenAlex counts 8 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at Beneficial Microbes.

Citations
8
Most cited in
2026 (7)
References
247
Authors
4

Abstract

Prebiotics are becoming increasingly recognized by consumers, health care professionals and regulators as important contributors to health. Nonetheless, the development, progress, and adoption of prebiotics is hindered by loose terminology, various misconceptions about sources and types of compounds that may be classified as prebiotics, and the lack of consensus on a definition that satisfies regulators. Evolving knowledge of the microbiome and its effects on host health has generated opportunities for modulation of the microbiota that can support host health. Various types of biotics - probiotics, prebiotics, and postbiotics, are compounds that either modulate the microbiota or arise from the microbiota, affecting health locally and distally. Each of these classes of biotic compounds have distinct, yet complementary benefits. While many scientists have proposed definitions for prebiotics, and there have been attempts by selected scientists to develop a 'consensus definition', the fact remains that globally, scientists, manufacturers, and marketers have adopted different definitions to suit their own interests and purposes, leading to confusion among consumers and health care professionals. The pathway to regulatory acceptance and to reduce/eliminate confusion is a definition that puts the focus on the consumer, and the benefits that consumers can realise from consumption of prebiotics. This consumer-focused approach, supported by science, will also align with regulators and support broader regulatory approval of prebiotics as a category. In this review, we discuss the history of prebiotics, and introduce criteria and a decision tree to classify compounds as prebiotics, supported by the scientific literature to date. This includes a summary of compounds that have been clearly recognised as prebiotics. We also review the microbiota, microbiome, and the various ways in which prebiotics can beneficially affect the microbiota and health. The safety and efficacy of prebiotics is also reviewed, along with effective doses and limitations associated with prebiotic use. This includes scientific tools and methods that help to establish the function, safe use and efficacy of a prebiotic. We also identify misconceptions that can be addressed in communications to consumers and health care professionals. Manufacturing guidelines and the current regulatory status of prebiotics in various jurisdictions are also reviewed. Collectively, this review provides an in-depth overview of the role for prebiotics to support the health of consumers. This consumer-focused approach provides clear criteria for the product category, safe use, effective communication of health benefits and limitations, and a pathway towards regulatory approval.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Saville, S., Younes, J., Paraskevakos, G., & Venema, K. (2017). The prebiotic landscape: history, health and physiological benefits, and regulatory challenges – an IPA perspective part 1. Beneficial Microbes, 16(1), 1–33. https://doi.org/10.1163/18762891-bja00056

MLA 9

Saville, S.H., et al. “The prebiotic landscape: history, health and physiological benefits, and regulatory challenges – an IPA perspective part 1.” Beneficial Microbes, vol. 16, no. 1, 2017, pp. 1–33. https://doi.org/10.1163/18762891-bja00056.

Chicago

Saville, S.H., J.A. Younes, George Paraskevakos, and Koen Venema. 2017. “The prebiotic landscape: history, health and physiological benefits, and regulatory challenges – an IPA perspective part 1.” Beneficial Microbes 16 (1): 1–33. https://doi.org/10.1163/18762891-bja00056.

Harvard

Saville, S. et al. (2017) ‘The prebiotic landscape: history, health and physiological benefits, and regulatory challenges – an IPA perspective part 1’, Beneficial Microbes, 16(1), pp. 1–33. doi:10.1163/18762891-bja00056.

IEEE

S. Saville, J. Younes, G. Paraskevakos, and K. Venema, “The prebiotic landscape: history, health and physiological benefits, and regulatory challenges – an IPA perspective part 1,” Beneficial Microbes, vol. 16, no. 1, pp. 1–33, 2017, doi: 10.1163/18762891-bja00056.

BibTeX

@article{saville2017prebiotic,
  title     = {{The prebiotic landscape: history, health and physiological benefits, and regulatory challenges – an IPA perspective part 1}},
  author    = {Saville, S.H. and Younes, J.A. and Paraskevakos, George and Venema, Koen},
  journal   = {Beneficial Microbes},
  year      = {2017},
  volume    = {16},
  number    = {1},
  pages     = {1--33},
  doi       = {10.1163/18762891-bja00056},
  url       = {https://doi.org/10.1163/18762891-bja00056}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology

  • prebiotics
  • gut microbiota
  • microbiome
  • probiotics
  • postbiotics

Work with this paper

Most-cited papers in Nursing

All highly cited Nursing papers

Questions about this paper

How do I cite this paper in APA style?

Saville, S., Younes, J., Paraskevakos, G., & Venema, K. (2017). The prebiotic landscape: history, health and physiological benefits, and regulatory challenges – an IPA perspective part 1. Beneficial Microbes, 16(1), 1–33. https://doi.org/10.1163/18762891-bja00056

How many times has this paper been cited?

8 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Beneficial Microbes.

Who wrote this paper?

S.H. Saville, J.A. Younes, George Paraskevakos, Koen Venema.

What is the DOI of this paper?

10.1163/18762891-bja00056. The permanent link is https://doi.org/10.1163/18762891-bja00056.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.